MiMedx Group (MDXG) Misses Q4 EPS by 3c

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.04, $0.03 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $87 million versus the consensus estimate of $85.12 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus